Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Avtandil Tataradze"'
Autor:
Ciro Esposito, Avtandil Tataradze, Udaya Valluri, Władysław Sułowicz, Michael Reusch, Evgeny Shutov, Nada Dimkovic, Branislav Andric
Publikováno v:
Nephrology Dialysis Transplantation
Background Roxadustat is an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of chronic kidney disease (CKD) anemia. Methods This Phase 3, multicenter, randomized, double-blind, placebo-controlled study examined p
Autor:
Tamar Tevdoradze, Gvantsa Metskhvarishvili, Nino Maglakelidze, Tamar Bagashvili, George Gazdeliani, Nino Buadze, Irma Tchokhonelidze, Rusudan Rusia, Nona Babutsidze, Merab Sutidze, Lela Beglarashvili, Nora Sarishvili, Natia Pachulia, Avtandil Tataradze, Tamar Kasradze, Dalakishvili Ketevan
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Kidney biopsy registry has been established in Georgia in 2011 by Dialysis, Nephrology and Kidney Transplantation Union of Georgia (DNT Union) to address the natural history of kidney disease, describe the clinical features, impro
Autor:
Michael Reusch, Branislav Andrić, Jonathan Barratt, Udaya Valluri, Michael Schömig, Christophe Mariat, Avtandil Tataradze
Publikováno v:
Nephrology Dialysis Transplantation
Background Roxadustat, an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor, is being evaluated for treatment of anaemia of chronic kidney disease (CKD). Methods This randomized, open-label, active-controlled Phase 3 study com
Autor:
Jonathan Barratt, Branislav Andric, Avtandil Tataradze, Michael Schömig, Michael Reusch, Udaya Valluri, Christophe Mariat
Publikováno v:
Nephrology Dialysis Transplantation. 37:805-805
Autor:
Christophe Mariat, Udaya Valluri, Avtandil Tataradze, Jonathan Barratt, Michael Schömig, Branislav Andrić, Michael Reusch
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anaemia in patients (pts) with chronic kidney disease (CKD). Efficacy and safety of roxadustat compared with darbepoet
Autor:
L Managadze, George Managadze, Avtandil Tataradze, Lela Beglarashvili, Nikoloz Kipshidze, A Chkhotua
Publikováno v:
International Journal of Clinical Medicine. :437-444
End-Stage Renal Disease (ESRD) represents one of the most challenging social and medical problems mainly due to substantial treatment-associated costs. The chronic nature of the disease needs expensive continuous care that majority of the patients ca
Autor:
Norberto Perico, Paolo Cravedi, M. P. Ghimire, Jeffrey B. Kopp, Rodolfo Flores Bravo, William G. Couser, Sanjib Kumar Sharma, Giuseppe Remuzzi, Bishnu Pahari, Avtandil Tataradze, Irma Tchokhonelidze, Annalisa Perna, Sanjeev Thapa, Sergio Carminati, Antonietta Chianca, Lela Beglarishvili, Nazmul Islam, Chyng Wen Fwu, Davitaia Tinatin, Bogdan Ene-Iordache, Anil Basnet, Paul W. Eggers
Publikováno v:
BMJ Open
Objective To assess the prevalence of microalbuminuria and kidney dysfunction in low-income countries and in the USA. Design Cross-sectional study of screening programmes in five countries. Setting Screening programmes in Nepal, Bolivia, the USA (Nat